FDA OKs First Gene Therapy for Hemophilia B

(MedPage Today) -- The FDA on Tuesday approved the first gene therapy for treating hemophilia B, a genetic bleeding disorder resulting from missing or insufficient levels of factor IX.
Etranacogene dezaparvovec (Hemgenix) is indicated for adults...